Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Patent
1995-02-17
1997-10-28
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
514312, 514314, 534759, 534820, 546156, A61K 31655, C07D21516, C07D21520
Patent
active
056818327
ABSTRACT:
Aroylaniline compounds which exhibit anti-retroviral activity, pharmaceutical compositions containing such aroylaniline compounds, and methods for treating a retroviral-infected host comprising administering an antiviral effective amount of an aroylaniline compound to a host.
REFERENCES:
patent: 2448853 (1948-08-01), Allen et al.
patent: 3211554 (1965-10-01), Dreyfuss
patent: 3562248 (1971-02-01), Jones et al.
patent: 4118232 (1978-10-01), Piller et al.
patent: 4167509 (1979-09-01), Parton
patent: 4542139 (1985-09-01), Hitzel et al.
patent: 4621088 (1986-11-01), Larselle et al.
patent: 5043257 (1991-08-01), Baettig et al.
Hurst et al., "The Prevention of Encephalitis Due to the Viruses of Eastern Equine Encephalomyelitis and Louping-Ill: Experiments with Trypan Red . . . ", Brit J. Pharmacol., 7, 455 (1952).
Balzarini et al., "Comparative Inhibitory Effects of Suramin and Other Selected Compounds on the Infectivity and Replication of Human T-Cell Lymphotropic Virus . . . ", Int. J. Cancer, 37, 451-457 (1986).
The Merck Index, eleventh edition, 1423 (1989.
Kaplan et al., "Lack of Response to Suramin in Patients with AIDS and AIDS-Related Complex", The American Journal of Medicine, 82, 615-620 (1987).
Erik De Clercq, II "Suramin in the treatment of AIDS: mechanism of action", Antiviral Research, 7, 1-10 (1987).
Alarcon et al., "Screening for new compounds with antiherpes activity", Antiviral Research, 4, 231-243 (1984).
Thorne et al., "Inactivation of Measles and Herpes Simplex Viruses by Trypan Blue", Journal Gen. Virol, 64, 1365-1368 (1983).
Akerfeldt et al., "Aromatic Sulfonic Acids as Vital Inhibitors. Structure-Activity Study using Rhino, Adeno 3, Herpes Simplex, and Influenza Viruses", Journal of Med. Chem., 14, 596-600 (1971).
Mohan et al. I, "Potential Anit-AIDS Agents. Synthesis and Antiviral Activity of Naphthalenesulfonic Acid Derivatives against HIV-1 and HIV-2", Journal Med. Chem., 34, 212-217 (1991).
Schols et al., "Flow Cytometric Method to Demonstrate Whether Anti-HIV-1 Agents Inhibit Virion Binding to T4+ Cells", Journal of Acquired Immune Deficiency Syndrome 2, 10-15 (1989).
De Clercq, I "Suramin: A Potent Inhibitor of the Reverse Transcriptase of RNA Tumor Viruses", Cancer Letters, 8, 9-22 (1979).
Broder et al., "Effects of Suramin on HTLV-III/LAV Infection Presenting As Kaposi's Sarcoma or Aids-Related Complex: Clinical Pharmacology and Suppression of . . . ", The Lancet, 2, 627-630 (1985).
Mohan et al. II, "Potential Anti-AIDS Agents. Synthesis and Antiviral Activity of Naphthalenesulfonic Acid Derivatives against HIV-1 and HIV-2", J Med. Chem., 34, 212-217 (1991).
Tan et al., "Potential Anti-AIDS Naphthalenesulfonic Acid Derivatives. Synthesis and Inhibition of HIV-1 Induced Cytopathogenesis and HIV-1 and HIV-2 Reverse . . . ", J. Med. Chem., 35, 4846-4853 (1992).
Mohan et al. III, "Structure-Activity Relationship Studies with Symmetric Naphthalenesulfonic Acid Derivatives. Synthesis and Influence of Spacer and . . . ", J. Med. Chem., 36, 1996-2003 (1993).
Gulakowski et al, J. Virological Methods, vol. 33, pp. 87-100 (1991).
Hein et al., "Optical Bleaching Agents. I. Derivatives of Dichloroaminostilbenedisulfonic Acid", Journal Of American Chemical Society, 76, 2725-2731 (1954).
Aleksandrov et al., "Diacyl and diacyldisulfamide derivatives of 4,4'-diaminostilbene-2,2'-disulfonic acid", Chemical Abstracts, 85, 359-360 (1976).
Ohyama et al., "Silver halide emulsion", Chemical Abstracts, 52, 8810-8811 (1958).
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005441, see BRN=2928122 & Chemical Abstracts, vol. 72, No. 24, 1970, Columbus, Ohio, US; abstract No. 122893.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005442, see BRT-2193992 & Kogyo Kagaku Zasshi, vol. 74, No. 1971, pp. 729-732.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005443, see BRN=2795085 & Yuki Gosei Kagaku Kyokaishi, vol. 30, 1972, pp. 818-819.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005444, see BRT=2785594 &Justus Liebigs Ann. Chem, vol. 692, 1966, pp. 26-41.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005445, see BRT-2928923 & Chemical Abstracts, vol. 72, No. 24, 1970, Columbus, Ohio, US; abstract No. 122893.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005446, see BRN=2826422 & Chemical Abstracts, vol. 53, No. 21, 10 Nov. 1959, Columbus, Ohio, US; abstract No. 19944b.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005447, see BRN=2797601 & Chemical Abstracts, vol. 72, No. 24, 1970, Columbus, Ohio, US; abstract No. 122893.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005448, see BRN=2928566 &Chemical Abstracts, vol. 72, No. 24, 1970, Columbus, Ohio, US; abstract No. 122893.
Database Crossfire, Beilstein lnformationssysteme, GmbH, Frankfurt DE, XP002005449, see BRN=3192102 & DE, C, 250 342 (Bayer & Co.) 1914.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005450, see BRN=2930702 & J. Soc. Dyers Colour., pp. 102-104.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005451, see BRN=4050045 & Biochemistry, vol. 18, 1979 pp. 4505-4510.
Database Crossfire, Beilstein Informationssysteme GmbH, Frankfurt DE, XP002005452, see BRN=2932158 & Yuki Gosei Kagaku Kyokaishi, vol. 29, 1971, pp. 519-522.
Burgess Edward
Gruszecka-Kowalik Ewa
Haugwitz Rudiger D.
Zalkow Leon
Georgia Tech Research Corporation
Higel Floyd D.
The United States of America as represented by the Department of
LandOfFree
Aroylaniline compounds, pharmaceutical compositions, and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aroylaniline compounds, pharmaceutical compositions, and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aroylaniline compounds, pharmaceutical compositions, and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026211